Clinical trial Recruiting at 1 site Interventional Ages 50 to 75

Prefrontal intermittent theta burst stimulation for thinking problems after ICU delirium

Official title: Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium: A Randomized Sham-Controlled Pilot Trial

Run by University of Florida · NCT07452939 · Data updated 2026-11-12

This trial will test whether intermittent theta burst brain stimulation can safely improve thinking, memory, and attention in older adults who had delirium during an ICU stay.

Quick facts

Study typeInterventional
Ages50 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedFebruary 13, 2026
Main results expectedMarch 21, 2027
Study endsApril 1, 2027
Registry record updatedMarch 11, 2026
Trial IDNCT07452939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking, community-dwelling adults age 50–75 who are about three months post-ICU discharge, had documented ICU delirium, can provide a family collateral, and have a MoCA score between 18 and 25.

Probably not a fit

People with pre-existing dementia or mild cognitive impairment before their ICU stay, a seizure disorder, major neurological disease, large focal brain lesions, or who cannot travel to the site are unlikely to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial enrolls community-dwelling adults aged 50–75 who are about three months after an ICU stay complicated by documented delirium and who have mild cognitive impairment on the MoCA (18–25). Participants receive either active intermittent theta burst stimulation (iTBS), a patterned form of transcranial magnetic stimulation, or a sham procedure applied over the prefrontal cortex across multiple sessions. The study tracks safety, feasibility, and changes in cognitive domains including attention, processing speed, memory, and executive function before and after the intervention. Results will guide whether larger trials of iTBS for post-delirium cognitive impairment are warranted.

Why it matters

Potential benefit: If successful, iTBS could provide a noninvasive option to improve daily thinking, attention, and memory in ICU survivors with lingering cognitive problems.

How similar studies have gone: TMS and iTBS have shown benefit for depression and some cognitive symptoms in other populations, but their use specifically for post-ICU delirium cognitive impairment is novel with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligible individuals must have experienced an ICU admission with documented delirium (confirmed via documented Confusion Assessment Method for the ICU score12 \[CAM-ICU\] or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition13(p5) \[DSM-5\] criteria)
* Age 50 to 75 years old
* 3 months post-ICU discharge at time of enrollment (defined as within 90 ± 14 days)
* English fluency
* Family or close friend for collateral
* Community-dwelling status
* Montreal Cognitive Assessment14 score between 18 and 25.

Exclusion Criteria:

* Diagnosis of mild cognitive impairment or dementia (prior to delirium episode)
* Seizure disorder
* Other significant neurologic disease (e.g., Parkinson's, Huntington's, Normal pressure hydrocephalus, tumor, progressive supranuclear palsy, multiple sclerosis, hematomas, traumatic or anoxic brain injury)
* Structural CT/MRI with evidence of infection or other clinically significant focal lesions (cortical strokes not large enough to distort anatomy and/or multiple lacunar infarctions ≤ 1.5cm and/or extensive white matter disease are allowed)
* Unstable or decompensated cardiac disease (e.g., \<3 months myocardial infarction, unstable angina, decompensated congestive heart failure NYHA class 3-4)
* Pacemaker
* Cochlear implants
* Implanted medication pumps
* Intracranial metal implants
* Previous TMS treatment
* Pregnancy (negative urine or serum b-HCG or history of prior surgical sterilization or post-menopausal status \[12 months or more of amenorrhea\])
* Current depressive disorder (Beck Depression Inventory score15 \<13)
* History of suicide attempts
* Schizophrenia
* Bipolar disorder
* Alcohol or substance abuse
* Severe visual/hearing impairment.
* Informant Questionnaire on Cognitive Decline in the Elderly16 (IQCODE) score ≥3.4 (suggesting prior cognitive decline)

Where it's running

  • University of Florida Shands Hospital
    Gainesville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.